These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39212993)

  • 41. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
    Brothers S; Viera A; Heimer R
    J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
    Trautmann S; Wittchen HU
    Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experience of patients on methadone maintenance treatment receiving take-home methadone doses during COVID-19 pandemic: A multi-site study from India.
    Kathiresan P; Patel V; Jangra J; Chattopadhyay A; Abdus S; Jadhav M; Rao R; Arya A; Bansal PD; Chinggouman C; Bhad R; Ambekar A; Agrawal A; Chatterjee B; Yadav D
    Asian J Psychiatr; 2024 May; 95():103979. PubMed ID: 38442535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
    Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
    Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid Use Disorder and Pregnancy.
    O'Donnell FT; Jackson DL
    Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.
    Dever JA; Hertz MF; Dunlap LJ; Richardson JS; Wolicki SB; Biggers BB; Edlund MJ; Bohm MK; Turcios D; Jiang X; Zhou H; Evans ME; Guy GP
    Public Health Rep; 2024; 139(4):484-493. PubMed ID: 38268479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing Outdated Methadone Regulations That Harm Pregnant Patients.
    McCarthy JJ; Jones HE; Terplan M; Rudolf VP; von Klimo MC
    J Addict Med; 2021 Apr; 15(2):93-95. PubMed ID: 32826620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States.
    Hochheimer M; Unick GJ
    Addict Behav; 2022 Jan; 124():107113. PubMed ID: 34543869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths - United States, 2002-2014.
    Jones CM; Baldwin GT; Manocchio T; White JO; Mack KA
    MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):667-71. PubMed ID: 27387857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there a disparity in medications for opioid use disorder based on race/ethnicity and gender? A systematic review and meta-analysis.
    Nedjat S; Wang Y; Eshtiaghi K; Fleming M
    Res Social Adm Pharm; 2024 Mar; 20(3):236-245. PubMed ID: 38101952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.
    Schwartz RP; Kelly SM; Mitchell SG; Dunlap L; Zarkin GA; Sharma A; O'Grady KE; Jaffe JH
    Contemp Clin Trials; 2016 Jul; 49():21-8. PubMed ID: 27282117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.
    Goedel WC; Shapiro A; Cerdá M; Tsai JW; Hadland SE; Marshall BDL
    JAMA Netw Open; 2020 Apr; 3(4):e203711. PubMed ID: 32320038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations.
    Jordan AE; Bachhuber MA; Tuazon E; Jimenez C; Lincourt P; Hussain S; Rubinfeld J; Cunningham CO
    Drug Alcohol Depend; 2024 May; 258():111283. PubMed ID: 38581920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.
    Nathan AS; Yang L; Yang N; Eberly LA; Khatana SAM; Dayoub EJ; Vemulapalli S; Julien H; Cohen DJ; Nallamothu BK; Baron SJ; Desai ND; Szeto WY; Herrmann HC; Groeneveld PW; Giri J; Fanaroff AC
    JAMA Cardiol; 2022 Feb; 7(2):150-157. PubMed ID: 34787635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of recovery peer navigators in retention in outpatient buprenorphine treatment: a retrospective cohort study.
    Giraldo A; Shah P; Zerbo E; Nyaku AN
    Ann Med; 2024 Dec; 56(1):2355566. PubMed ID: 38823420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Buprenorphine Treatment Divide by Race/Ethnicity and Payment.
    Lagisetty PA; Ross R; Bohnert A; Clay M; Maust DT
    JAMA Psychiatry; 2019 Sep; 76(9):979-981. PubMed ID: 31066881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.